We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
ZAVICEFTA (Pfizer Australia Pty Ltd)
Product name
ZAVICEFTA
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
195 (255 working days)
Active ingredients
avibactam sodium; ceftazidime pentahydrate
Registration type
EOI
Indication
ZAVICEFTA (powder for injection) is now also indicated for the treatment of the following infections in infants and paediatric patients (≥ 3 months to < 18 years) (see sections 4.4 Special warnings and precautions for use and 5.1 Pharmacodynamic properties):
- Complicated intra-abdominal infection (cIAI) in combination with metronidazole.
- Complicated urinary tract infection (cUTI) including pyelonephritis